Download video

Lasofoxifene vs fulvestrant for locally advanced/metastatic ER+/HER2- breast cancer: ELAINE trial

246 views

ecancer

2 years ago

Lasofoxifene vs fulvestrant for locally advanced/metastatic ER+/HER2- breast cancer: ELAINE trial

Lasofoxifene vs fulvestrant for locally advanced/metastatic ER+/HER2- breast cancer: ELAINE trial

Lasofoxifene vs fulvestrant for locally advanced\/metastatic ER+\/HER2- breast cancer: ELAINE trial
4:34
Lasofoxifene vs fulvestrant for locally advanced\/metastatic ER+\/HER2- breast cancer: ELAINE trial
by ecancer
ER PR and Her2 new Test for Breast Cancer| Use Result and Price (in Hindi)
6:23
ER PR and Her2 new Test for Breast Cancer| Use Result and Price (in Hindi)
by Dr. santosh medical awareness campaign
HER2 Positive Breast Cancer: Everything You Must Know
13:08
HER2 Positive Breast Cancer: Everything You Must Know
by Breast Cancer School for Patients
HER2-positive Breast Cancer - How does it work? A doctor explains with simple images.
3:11
HER2-positive Breast Cancer - How does it work? A doctor explains with simple images.
by Doctor Grew Explains Cancer
Treatment Sequencing Strategies in HER2-Positive Breast Cancer
5:36
Treatment Sequencing Strategies in HER2-Positive Breast Cancer
by Breast Cancers Today
Hormone Receptor-Positive and HER2-Positive Breast Cancer: A Medical Update
1:08:15
Hormone Receptor-Positive and HER2-Positive Breast Cancer: A Medical Update
by Living Beyond Breast Cancer
MONARCH 2: abemaciclib added to fulvestrant shows OS benefit in HR+\/HER2- advanced breast cancer
5:12
MONARCH 2: abemaciclib added to fulvestrant shows OS benefit in HR+\/HER2- advanced breast cancer
by VJOncology
HER2-Low Breast Cancer: DESTINY or Good Science?
11:12
HER2-Low Breast Cancer: DESTINY or Good Science?
by Cancer Treatment Updates
Mafalda Oliveira, SABCS 2022: Camizestrant vs fulvestrant for advanced ER+ HER2- breast cancer
6:55
Mafalda Oliveira, SABCS 2022: Camizestrant vs fulvestrant for advanced ER+ HER2- breast cancer
by Touch Medical Media
Optimizing treatment approaches for ER+\/HER2- breast cancer
1:19
Optimizing treatment approaches for ER+\/HER2- breast cancer
by VJOncology
Study of SACI-IO for Hormone Receptor Positive Metastatic Breast Cancer
4:59
Study of SACI-IO for Hormone Receptor Positive Metastatic Breast Cancer
by Dana-Farber Cancer Institute
Overcoming Therapy Resistant ER Positive Breast Cancer With Lasofoxifene – Emily Zboril, MS
3:22
Overcoming Therapy Resistant ER Positive Breast Cancer With Lasofoxifene – Emily Zboril, MS
by MD Newsline